Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis José Antonio Rodríguez Portal; Noé Brito García; Petra Díaz del Campo Fontecha; Claudia Valenzuela; Ana María Ortiz; M. Asunción Nieto; Natalia Mena-Vázquez; Esteban Cano-Jiménez; Iván Castellví; Myriam Aburto; Gema Bonilla; María Vanesa Hernández Hernández; Félix Manuel Francisco Hernández; María Correyero Plaza; Isabel Castrejón; Miguel Ángel Abad Hernández; Javier Narváez;

Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians Beatriz Frade-Sosa; Raimon Sanmartí;